Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07212335) titled 'Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in the Treatment of Long-Term Cytopenia After CAR-T Therapy' on Sept. 30.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Condition:
Immune Effector Cell Associated Hematotoxicity
Intervention:
Biological: Mesenchymal Stem Cell Infusion
Recruitment Status: Not recruiting
Phase: Early Phase 1
Date of First Enrollment: October 1, 2025
Target Sample Si...